Michael Spencer Chapman
-
- Cancer Genomics and Diagnostics 7
- Hematology top 10%
- Acute Myeloid Leukemia Research 3
- Hematopoietic Stem Cell Transplantation 2
-
- Genomics and Rare Diseases 1
- Chronic Lymphocytic Leukemia Research 1
- Mesenchymal stem cell research 1
-
- Genomics and Rare Diseases 1
- Chronic Lymphocytic Leukemia Research 1
- Mesenchymal stem cell research 1
-
- Single-cell and spatial transcriptomics 4
- CRISPR and Genetic Engineering 2
- Co-authors
- Peter J. CampbellEmily MitchellNicholas WilliamsJyoti NangaliaTim CoorensYvette HooksPhilip S. RobinsonLuiza Moore
- Cited by
- Cancer ResearchHematologyGenetics
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
Michael Spencer Chapman
15 papers receiving 276 citations
Peers
Comparison fields: 5 of 51
- Cancer Research 105
- Hematology 74
- Genetics 44
- Genetics 69
- Molecular Biology 155
Countries citing papers authored by Michael Spencer Chapman
This map shows the geographic impact of Michael Spencer Chapman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Spencer Chapman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Spencer Chapman more than expected).
Fields of papers citing papers by Michael Spencer Chapman
This network shows the impact of papers produced by Michael Spencer Chapman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Spencer Chapman. The network helps show where Michael Spencer Chapman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Spencer Chapman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 36 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 6 | |
| 5 | 2023 | 27 | |
| 6 | 2022 | 3 | |
| 7 | 2021 | 84 | |
| 8 | 2021 | 75 | |
| 9 | 2021 | 4 | |
| 10 | 2020 | 2 | |
| 11 | 2018 | 1 | |
| 12 | 2015 | 3 | |
| 13 | 2002 | 12 | |
| 14 | 1996 | 11 | |
| 15 | 1996 | 4 |
About Michael Spencer Chapman
Michael Spencer Chapman is a scholar working on Hematology, Cancer Research and Genetics, having authored 15 papers that have together received 277 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (7 papers), Single-cell and spatial transcriptomics (4 papers), Acute Myeloid Leukemia Research (3 papers), CRISPR and Genetic Engineering (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Genomics and Rare Diseases (1 paper), Chronic Lymphocytic Leukemia Research (1 paper) and Mesenchymal stem cell research (1 paper). The work is most often cited by research in Cancer Research (105 citations), Hematology (74 citations) and Genetics (44 citations). Michael Spencer Chapman has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Peter J. Campbell, Emily Mitchell, Nicholas Williams, Jyoti Nangalia, Tim Coorens, Yvette Hooks, Philip S. Robinson, Luiza Moore, Kevin J. Dawson and Ana Cvejic. Their work appears in journals such as Nature, Nature Medicine and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.